Risks related to demand, regulations, infrastructure, public safety, and labor disputes in the China business
First written in FY2016. 18 of 37 entries say "Mitigated", first in FY2019-Q3. Latest entry: 2026-11-13.
Tensho Electric Industries moved to the "Worse" side of this theme in 2016, 8 years before the typical company in this theme (2024).
The whole theme swung hardest in 2018: 5 of 13 companies on the "Worse" side.
5 other companies' latest entry also says "Mitigated".
- 2026-11-13MitigatedRevision to earnings forecast
「中国成形関連事業では、引き続き物流産業資材及び機構品部品の販売拡大に努めております。この結果、売上高３億17百万円（前年同期比25.8％増）、セグメント利益19百万円（前年同期はセグメント損失２百万円）となりました。」
中国事業の需要・販売面で、売上増加と黒字化により実績上の影響が緩和している。 - FY2026MitigatedAnnual report
「In the China molding-related business, we continued working to expand sales of logistics industry materials and mechanism-component parts. As a result, sales were ¥551 million, up 3.6% from the previous consolidated fiscal year, and segment profit was ¥7 million, compared with a segment loss of ¥28 million in the previous consolidated fiscal year.」
Revenue in the China business increased, and segment earnings also turned from a loss to a profit. The impact on actual results of the risks that had emerged in demand and sales in China has eased from the previous fiscal year. - 2026-05-14MitigatedResults
「この結果、売上高５億51百万円（前連結会計年度比3.6％増）、セグメント利益７百万円（前連結会計年度はセグメント損失28百万円）となりました。」
中国事業の需要・販売面に関する実績影響は、前年度の損失から利益へ転じる形で緩和した。 - FY2026-H1Lower revenue and reduced lossesAnnual report
「In the China molding-related business, we continued working to expand sales of logistics industry materials and mechanism-component parts. As a result, sales were ¥252 million, down 17.1% year on year, and the segment posted a loss of ¥2 million, compared with a segment loss of ¥3 million in the previous year.」
While revenue in the China business declined 17.1% year on year, the segment loss narrowed from ¥3 million to ¥2 million. Uncertainty related to demand and sales remains. - FY2025WorsenedAnnual report
「In the China molding-related business, we continued working to expand sales of logistics industry materials and mechanism-component parts. As a result, sales were ¥533 million, up 19.6% from the previous consolidated fiscal year, while the segment posted a loss of ¥28 million, compared with segment profit of ¥9 million in the previous consolidated fiscal year.」
Although revenue in the China business increased, segment earnings turned from a profit to a loss, and risks related to demand and sales have again emerged in profitability. - FY2025-H1MitigatedAnnual report
「In the China molding-related business, we continued working to expand sales of logistics industry materials and mechanism-component parts. As a result, sales were ¥304 million, up 35.3% year on year, and the segment posted a loss of ¥3 million, compared with a segment loss of ¥18 million in the previous year.」
Revenue in the China business increased on expanded sales, while the segment loss narrowed from ¥18 million to ¥3 million. Although the impact on actual results of the risks that had emerged in demand and sales has eased from the previous fiscal year, a loss remains. - FY2024WorsenedAnnual report
「In the China molding-related business, sales of IC trays were strong in the previous fiscal year in line with stay-at-home demand accompanying the spread of COVID-19, but sales fell below plan in the current fiscal year partly due to the subsequent reversal of that demand. As a result, revenue was ¥445 million, down 38.9% from the previous consolidated fiscal year, and segment profit was ¥9 million, down 86.2% from the previous consolidated fiscal year.」
Risks related to demand and sales in the China business were reflected in actual results, with revenue declining due to a reversal in IC tray demand and segment profit also falling significantly. - FY2024-Q3WorsenedAnnual report
「In the China molding-related business, sales of IC trays linked to stay-at-home demand during the previous fiscal year were strong, but the resulting reaction also contributed to an outcome below plan this fiscal year. As a result, sales were ¥356 million, down 39.8% year on year, and segment profit was ¥3 million, down 95.6%.」
The China business fell short of its plan due to a reversal in IC tray demand, and revenue and segment profit declined significantly. The impact of risks related to demand and sales in China has worsened in actual results. - FY2024-Q2WorsenedAnnual report
「In the China molding-related business, sales of IC trays linked to stay-at-home demand during the previous fiscal year were strong, but the resulting reaction also contributed to an outcome below plan this fiscal year. As a result, sales were ¥225 million, down 42.2% year on year, and the segment posted a loss of ¥18 million, compared with segment profit of ¥65 million in the same quarter of the previous year.」
Revenue in the China business declined due to a reversal in IC tray demand, and segment earnings turned from a profit to a loss. Risks related to demand and sales in China have worsened in actual results. - FY2023MitigatedAnnual report
「In the China molding-related business, orders from major customers increased substantially, while orders for high-margin products also remained strong. As a result, sales were ¥729 million, up 51.1% from the previous consolidated fiscal year, and segment profit was ¥71 million, up 119.1%.」
Higher orders and strong performance by high-margin products in the China business resulted in higher revenue and profit, further mitigating the impact on actual results of the previously evident risks related to demand and sales. - FY2023-Q3MitigatedAnnual report
「In the China molding-related business, orders from major customers increased substantially, while orders for high-margin products also remained strong. As a result, sales were ¥592 million, up 72.1% year on year, and segment profit was ¥83 million, up 193.4%.」
Increased orders and strong orders for high-margin products resulted in higher revenue and profit in the China business, further mitigating the impact on actual results of the previously evident risks related to demand and sales. - FY2023-Q2MitigatedAnnual report
「In the China molding-related business, orders from major customers increased substantially, while orders for high-margin products also remained strong. As a result, sales were ¥389 million, up 76.0% year on year, and segment profit was ¥65 million, up 272.9%.」
Increased orders and strong orders for high-margin products resulted in higher revenue and profit in the China business, further mitigating the impact on actual results of the previously evident risks related to demand and sales. - FY2023-Q1MitigatedAnnual report
「In the China molding-related business, orders from major customers increased substantially, while orders for high-margin products also remained strong. As a result, sales were ¥168 million, up 48.9% year on year, and segment profit was ¥28 million, up 260.0%.」
Increased orders and strong orders for high-margin products increased revenue and segment profit in the China business, further mitigating the impact on actual results of the risks that had emerged in relation to weak sales and profitability. - FY2022MitigatedAnnual report
「In the China molding-related business, the impact of the spread of COVID-19 remained limited. We worked to produce and sell products while thoroughly reducing costs and securing profit margins. As a result, sales were ¥482 million, up 33.4% from the previous consolidated fiscal year, and segment profit was ¥32 million, up 212.7%.」
The impact of the infectious disease on the China business was limited, and revenue and profit increased. The impact on actual results of the previously evident effects of weak sales and profitability issues has eased further. - FY2022-Q3MitigatedAnnual report
「In the China molding-related business, the impact of the spread of COVID-19 subsided, and we worked to produce and sell products while thoroughly reducing costs and securing profit margins. As a result, sales were ¥344 million, up 33.3% year on year, and segment profit was ¥28 million, up 231.7% year on year.」
The company explained that the impact of the infectious disease had subsided, and both revenue and segment profit exceeded the same period of the previous year. The impact on actual results of risks related to the infectious disease and weak sales has eased from the previous fiscal year. - FY2022-Q2MitigatedAnnual report
「In the China molding-related business, the impact of the spread of COVID-19 subsided, and we worked to produce and sell products while thoroughly reducing costs and securing profit margins. As a result, sales were ¥221 million, up 22.8% year on year, and segment profit was ¥17 million, up 139.0% year on year.」
The company explained that the impact of the infectious disease had subsided, and both revenue and segment profit exceeded the same period of the previous year. The impact on actual results of the risks that had emerged in demand and sales has eased from the previous fiscal year. - FY2022-Q1MitigatedAnnual report
「In the China molding-related business, the impact of the spread of COVID-19 subsided, and we worked to produce and sell products while thoroughly reducing costs and securing profit margins. As a result, sales were ¥113 million, up 50.8% year on year, and segment profit was ¥7 million, up 5,272.8% year on year.」
The company explained that the impact of the infectious disease had subsided, and both revenue and segment profit exceeded the same period of the previous year. The impact on actual results of risks related to the infectious disease and weak sales has eased from the previous fiscal year. - FY2021WorsenedAnnual report
「In the China molding-related business, the spread of COVID-19 and delays in the schedules of new projects resulted in sales of ¥361 million, down 18.4% from the previous consolidated fiscal year, and segment profit of ¥10 million, down 75.0%.」
Revenue and profit in the China business declined due to the infectious disease and delays in the schedules of new projects, and the impact of risks related to demand and project progress became evident for the full fiscal year as well. - FY2021-Q3WorsenedAnnual report
「In the China molding-related business, the spread of COVID-19 and delays in the schedules of new projects resulted in sales of ¥258 million, down 20.0% year on year, and segment profit of ¥8 million, down 74.8% year on year.」
Revenue and profit in the China business declined due to the spread of the infectious disease and delays in the schedules of new projects, with revenue down 20.0% year on year and segment profit down 74.8%. - FY2021-Q2Limited impact from infectious disease; lower sales and profitAnnual report
「In the China molding-related business, restrictions on production activity resulting from the spread of COVID-19 were limited. However, increased sales activity expenses resulted in sales of ¥180 million, down 5.5% year on year, and segment profit of ¥7 million, down 43.5% year on year.」
Although restrictions on production activities in the China business were limited, revenue and profit declined due to higher sales-related expenses. The business impact of the infectious disease coexists with the existing uncertainty surrounding demand and sales in China. - FY2020MitigatedAnnual report
「In the China molding-related business, our focus on expanding sales, mainly of logistics industry materials and mechanism-component parts, resulted in sales of ¥443 million, up 15.8% from the previous consolidated fiscal year. Through thorough cost reductions, particularly in factory expenses, segment profit was ¥41 million, up 59.4% from the previous consolidated fiscal year.」
Revenue and profit in the China business both increased, further mitigating in actual results the previously evident risks related to weak sales and losses. - FY2020-Q3MitigatedAnnual report
「In the China molding-related business, our focus on expanding sales, mainly of logistics industry materials and mechanism-component parts, resulted in sales of ¥323 million, up 10.6% year on year. Through thorough cost reductions, particularly in factory expenses, segment profit was ¥34 million, up 39.1% year on year.」
Both revenue and segment profit in the China business exceeded the same period of the previous year, and risks related to weak sales and profitability have been further mitigated from the previous fiscal year. There is no statement that risks related to demand, regulations and infrastructure have been eliminated. - FY2020-Q2MitigatedAnnual report
「In China, our focus on expanding sales, mainly of logistics industry materials and mechanism-component parts, resulted in sales of ¥190 million, up 25.2% year on year. Through thorough cost reductions and other measures, segment profit was ¥13 million, up 50.3% year on year.」
Revenue in the China business rose 25.2% from the same quarter of the previous year, and segment profit improved to ¥13 million. Risks related to weak sales and profitability have been further mitigated from the previous fiscal year. There is no statement that risks related to demand, regulations and infrastructure have been eliminated. - FY2020-Q1MitigatedAnnual report
「In China, efforts to expand sales of logistics industry materials and mechanism-component parts resulted in sales of ¥75 million, up 49.1% year on year. Despite pursuing cost reductions and cuts in selling, general and administrative expenses, the segment posted a loss of ¥0 million, compared with a loss of ¥4 million in the same quarter of the previous year.」
In the China business, revenue rose 49.1% year on year on improved sales, while the segment loss narrowed from ¥4 million to ¥0 million. There is no statement that risks related to demand, regulations and infrastructure have been eliminated. - FY2019MitigatedAnnual report
「In the China molding-related business, our focus on expanding sales, mainly of logistics industry materials and mechanism-component parts, resulted in sales recovering to ¥382 million, up 15.5% from the previous consolidated fiscal year. Through thorough cost reductions, particularly in factory expenses, segment profit increased to ¥26 million, up 53.7% from the previous consolidated fiscal year.」
Demand and sales in the China business are on a recovery trend, with both revenue and segment profit exceeding the same period of the previous year. Although there is no statement that risks related to demand, regulations and infrastructure have been eliminated, actual results are showing continued improvement. - FY2019-Q3MitigatedAnnual report
「In the China molding-related business, our focus on expanding sales, mainly of logistics industry materials and mechanism-component parts, resulted in sales recovering to ¥292 million, up 21.9% year on year. Through thorough cost reductions, particularly in factory expenses, segment profit increased to ¥24 million, up 194.5% year on year.」
Revenue in the China business rose 21.9% from the same quarter of the previous year, while segment profit improved to ¥24 million. Although there is no statement that the risks related to demand and sales have been completely eliminated, weak sales and profitability have improved from the previous quarter. - FY2019-Q2Sluggish sales persist; profitability improvesAnnual report
「Although we focused on expanding sales, mainly of logistics industry materials and mechanism-component parts, conditions remained difficult. Sales were ¥152 million, down 0.9% year on year, while segment profit was ¥8 million, up 83.1% year on year, owing to thorough cost reductions and other measures.」
In the China business, difficult sales conditions and a 0.9% year-on-year decline in revenue continued, while cost reductions and other measures resulted in segment profit of ¥8 million, an improvement from the loss recorded in the same period of the previous year. - FY2019-Q1WorsenedAnnual report
「Although we worked to expand sales of logistics industry materials and mechanism-component parts in China, sluggish sales persisted and conditions remained difficult. As a result, sales were ¥50 million, down 35.7% year on year. Despite pursuing thorough cost reductions and cuts in selling, general and administrative expenses, the segment posted a loss of ¥4 million, compared with a profit of ¥0 million in the same quarter of the previous year.」
In the China business, weak sales continued, with revenue down 35.7% year on year and segment earnings turning from a profit in the same period of the previous year to a ¥4 million loss. The risks related to demand and sales in China have worsened in actual results. - FY2018Slight full-year sales growth and return to profitability alongside continued challenging conditionsAnnual report
「Although we worked to expand sales of logistics industry materials and mechanism-component parts, primarily to Japanese companies, difficult conditions continued. Sales were ¥331 million, up 0.3% year on year. The addition of a function as a point of contact for mold orders in China, together with thorough cost reductions and other measures, resulted in segment profit of ¥17 million, compared with a loss of ¥23 million in the same period of the previous year.」
Although the Company states that challenging conditions continued in the China business, full-year net sales increased slightly and the segment result moved from a loss to a profit. - FY2018-Q3Higher sales and return to profitability alongside continued challenging conditionsAnnual report
「Although we worked to expand sales of logistics industry materials and mechanism-component parts in China, difficult conditions continued. Sales were ¥239 million, up 1.7% year on year. Through thorough cost reductions, particularly in factory expenses, the segment posted a profit of ¥8 million, compared with a loss of ¥28 million in the same quarter of the previous year.」
Although challenging conditions continued in terms of demand and sales in the China business, net sales increased year on year and the segment result moved from a loss to a profit. - FY2018-Q2Weak sales continuing, return to profitabilityAnnual report
「Although we focused on expanding sales, mainly of logistics industry materials and mechanism-component parts, conditions remained difficult. Sales were ¥153 million, down 1.5% year on year, and sluggish sales persisted. However, segment profit was ¥4 million, compared with a loss of ¥38 million in the same quarter of the previous year, owing to thorough cost reductions and other measures.」
While weak sales and declining net sales continued in the China business, the segment result improved from a loss of ¥38 million in the same period of the previous year to a profit of ¥4 million. Demand-related risks coexisted with improvement in profitability. - FY2018-Q1Sluggish sales persist; profitability improvesAnnual report
「Although we worked to expand sales of logistics industry materials and mechanism-component parts in China, sluggish sales persisted and conditions remained difficult. As a result, sales were ¥78 million, down 4.9% year on year. Segment profit was ¥0 million, compared with a loss of ¥1 million in the same quarter of the previous year, owing to thorough cost reductions and cuts in selling, general and administrative expenses.」
Weak sales in the China business continued, with net sales down 4.9% year on year. However, the segment loss was eliminated through cost and selling, general and administrative expense reductions, so the actual effects of the risks were mixed, with both deterioration and improvement. - FY2017WorsenedAnnual report
「Tensho Plastic (Changzhou) Co., Ltd. manufactures and sells molded plastic products, but faces various risks, including local demand trends, regulations, infrastructure such as electricity, water, and transport, deteriorating public safety, and labor disputes. / Net sales declined significantly to ¥330 million, down 32.3% year on year. Although the Company pursued thorough cost reductions, primarily in factory expenses, the segment reported a loss of ¥23 million, compared with a loss of ¥8 million in the same period of the previous year.」
The Company describes risks in the China business related to demand, regulations, infrastructure, public safety, and labor disputes, and actual declines in sales and widening segment losses have occurred. - FY2017-Q3WorsenedAnnual report
「Although we are working to expand sales of logistics industry materials and mechanism-component parts, conditions remain extremely difficult. Sales fell substantially to ¥235 million, down 35.9% year on year. Despite pursuing thorough cost reductions, particularly in factory expenses, the segment posted a loss of ¥28 million, compared with a loss of ¥4 million in the same quarter of the previous year.」
Weak demand and sales in the China business continued, with net sales down 35.9% year on year. Although cost reductions were being pursued, the segment loss widened from the year-earlier period. - FY2017-Q2WorsenedAnnual report
「The China business primarily comprises sales of logistics industry materials for the domestic Chinese market. Although we have focused on expanding sales, conditions remained difficult. Sales were ¥155 million, down 34.6% year on year, and the segment posted a loss of ¥38 million, compared with a loss of ¥19 million in the same quarter of the previous year.」
Weak demand and sales in the China business continued, with net sales down 34.6% year on year, while the segment loss also widened. The existing demand risk related to the China business was further reflected in the figures. - FY2017-Q1WorsenedAnnual report
「In China, sales consist mainly of logistics industry materials. During the cumulative first quarter, the business remained in a difficult environment as sluggish sales persisted. As a result, sales were ¥82 million, down 32.1% year on year, and the segment posted a loss of ¥1 million, compared with a loss of ¥7 million in the same quarter of the previous year.」
Weak sales in the China business continued, with net sales down 32.1% year on year. The failure to achieve a full-scale recovery, which has continued from the previous fiscal year, was reflected in the figures for the quarter as well. - FY2016First statedAnnual report
「Tensho Plastic (Changzhou) Co., Ltd. recorded an impairment loss of ¥55 million as an extraordinary loss, resulting in net income attributable to owners of the parent of ¥450 million. In China, sales were at a similar level to the previous consolidated fiscal year, and a full-scale recovery has yet to be achieved.」
Sales in the China business have not fully recovered, and an impairment loss of ¥55 million was incurred during the fiscal year. Local demand, regulations, infrastructure, public safety, and labor disputes are also listed as risk factors.